ArticleJournal of clinical and experimental hepatology2016
Limited Fibrosis Progression but Significant Mortality in Patients Ineligible for Interferon-Based Hepatitis C Therapy.
Manhal Izzy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.